Wanda Acquired by EMV Capital to Advance Predictive Chronic Care Platform

Recently, VCBeat (WeChat official account: vcbeat) learned that venture capital firm EMV Capital has announced the acquisition of U.S. digital health company Wanda, with the purchase price undisclosed. This move will increase Wanda’s market share in North America and facilitate its entry into the European market.

Wanda is a San Francisco-based digital health startup founded in 2011 that has successfully commercialized its products. Wanda is dedicated to integrating machine learning, virtual care, and modern software to derive health insights from real-time patient data. By facilitating communication among physicians, patients, and caregivers, the company enhances the utility and efficiency of telemedicine and patient management services, empowering users to better control the risks and treatment outcomes of chronic conditions such as heart disease.

Clinical evidence demonstrates that Wanda’s predictive patient care platform enhances patient adherence and treatment outcomes while significantly reducing treatment costs. Leveraging machine learning algorithms, the platform can predict seven days in advance whether discharged patients require readmission, enabling clinically guided interventions to prevent avoidable hospitalizations.

The platform’s core features include early warning for clinical deterioration, advance care management, virtual examinations, and multimodal patient engagement.

Deterioration Warning: Machine learning algorithms can identify 90% of high-risk chronic disease deteriorations seven days in advance, enhancing safety for high-risk patients.

Proactive Care Management: Real-time monitoring of high-risk chronic disease exacerbations to optimize therapeutic interventions and implement patient care plans.

Virtual Check-up: Continuously collect data on patients' physiological, behavioral, and psychological status to improve patient-centered care services.

Multimodal Patient Engagement: Connecting patients and physicians through communication channels such as video, IVR (Interactive Voice Response), SMS, and mobile apps, while conducting health data assessments to ensure patient adherence to care plans.

“EMV Capital’s B2B-focused investment and corporate partnership network will accelerate Wanda’s growth. The recognition of Wanda’s products and technology by our partners and customers is truly encouraging,” said Foad Dabiri, Co-founder and CEO of Wanda.

“Wanda is most welcome to join EMV Capital,” said Dr. Ilian Iliev, Managing Director of EMV Capital. “Over the past few years, Wanda has demonstrated significant influence. Our investment in Wanda aligns with our philosophy of supporting AI platforms that can achieve continuous scale-up through industry collaboration.”

Wanda’s Business Director, Bill Bassett, stated: “We intend to expand Wanda’s commercial scale and emerge as a novel provider and payer in the healthcare sector. The success achieved by Accountable Care Organizations (ACOs), post-acute care providers, and Physician Practice Management Companies (PPMCs)—which have improved quality of life, mitigated the impact of chronic diseases such as heart disease, and reduced overall healthcare costs—is worthy of our emulation.”

A recent study by the U.S. Centers for Disease Control and Prevention estimates that 1.1 billion adults worldwide are affected by heart disease; in the United States alone, annual spending on heart disease treatment amounts to $199 billion. By 2022, the global market size for connected healthcare solutions is projected to reach $105 billion. Driven by the chronic disease crisis caused by heart disease, global demand for solutions similar to Wanda’s is expected to expand further.

EMVC is a London-based investment firm primarily focused on B2B companies in the fields of high technology, clean energy, resource efficiency, circular economy, smart cities, and transportation. Its investment areas include robotics, artificial intelligence, machine vision, materials science, the Internet of Things (IoT), advanced engineering, and power electronics. EMVC mainly invests in early-stage technology companies and has led structural investments for globally renowned corporations such as ABB, Philips Lighting, Evonik Industries, Mitsubishi, and Flex.

In addition to investment, EMVC also provides related consulting services. EMVC customizes investment strategies for companies and has built an investor network comprising family enterprises, wealth management firms, venture capital institutions, and VC funds, thereby establishing its inherent business model.

(Compiled by Tang Lulu)